Drug intelligence / Profile preview

ziyuglycoside II

Development stage
Preclinical
Lead developer
West China Hospital of Sichuan University
Modality
Small Molecules
Administration
Oral
01

Overview

Ziyuglycoside II is a triterpene saponin derived from the root of *Sanguisorba officinalis* L. (Diyu). It is the primary active constituent of Diyushengbai tablets, a traditional Chinese medicine formulation widely used to prevent and treat leukopenia, particularly that induced by chemotherapy or immunosuppressive agents like azathioprine. The compound promotes hematopoiesis by stimulating the proliferation and differentiation of hematopoietic stem and progenitor cells (HSPCs), including long-term and short-term hematopoietic stem cells (LT-HSCs and ST-HSCs) and multipotent progenitor cells (MPPs). Beyond its hematopoietic effects, ziyuglycoside II has been investigated for its anti-inflammatory and anti-tumor properties in various research settings.

Brand names
Diyushengbai
Other names
Ziyuglycoside 2Ziyuglycoside2Ziyuglycoside-23β,19α-dihydroxyurs-12-en-28-oic acid 3-O-α-L-arabinopyranoside
02

Targets

CXCR4 (C-X-C motif chemokine receptor 4)ERBB2 (Erb-b2 receptor tyrosine kinase 2)

Beyond the preview

Go deeper on ziyuglycoside II.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ziyuglycoside II.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call